FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Lasix® Retard

Sanofi AB

Depotkapsel, hård 60 mg
(grön/gul, avlång, storlek 7,0 mm x 19,0 mm)

Loop-diuretikum och blodtryckssänkande medel med furosemid i retarderad form

Aktiv substans:
ATC-kod: C03CA01
Utbytbarhet: Ej utbytbar
Läkemedel från Sanofi AB omfattas av Läkemedelsförsäkringen.
Vad innebär restanmält läkemedel?
Information om restanmält läkemedel
Vissa förpackningar av Lasix® Retard Depotkapsel, hård 60 mg är restanmälda hos Läkemedelsverket. Kontrollera lagerstatus för att se om ditt apotek har läkemedlet i lager.

Kontakta ditt apotek eller din läkare om du har frågor.

Visa tillgänglig information från Läkemedelsverket

Burk 100 kapsel/kapslar (vnr 135509)
Inte utbytbart.
Alternativ förpackning.
Alternativt läkemedel med samma verksamma ämne.
Startdatum: 2024-01-16
Prognos för slutdatum: 2024-07-05
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Furosemid

Miljörisk: Användning av furosemid har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Det kan inte uteslutas att furosemid är persistent, då data saknas.
Bioackumulering: Furosemid har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.5*10-6*A*(100-R)


PEC = 0.663 µg/L


Where:
A = 4421.6437 kg (total sold amount API in Sweden year 2019, data from IQVIA)
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)
P = number of inhabitants in Sweden = 9*106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref I)
D = factor of dilution of waste water by surface water flow = 10 (ECHA default) (Ref I)


Predicted No Effect Concentration (PNEC)

Ecotoxicological studies

Algae (Desmodesmus subspicatus):
EC10 72 h (growth rate) = 43 640 µg/L
EC50 72 h (growth rate) = 428 670 µg/L
NOEC 72 h (growth rate) = 3 230 µg/L

(OECD 201)
(Ref II)


Crustacean (Daphnia magna):

EC50 48 h (immobilization) = > 100 000 μg/L

(OECD 202)

(Ref III)


Chronic toxicity Crustacean (Daphnia magna):

NOEC 21 days (reduction in reproduction) = 3 090 µg/L

EC10 21 days (reduction in reproduction) = 2 010 µg/L
(OECD 211)
(Ref IV)


Fish (Leuciscus idus f. melanotus):
LC50 96 h (mortality) = > 500 000 µg/L

(Protocol: non-standard. Additional information: static test. 5 test concentrations. 10 fish/test concentration. pH 8, oxygen content 7 mg/l, temperature 20 °C)

(Ref V)


Other ecotoxicity data:

PNEC = 40.2 μg/L


The PNEC (μg/L) = lowest EC10/50 (assessment factor of 50 due to two long term toxicity endpoints available for two trophic levels (algae, daphnia))


The most sensitive species was Daphnia magna for which the EC10 was used.


Environmental Risk Classification (PEC/PNEC ratio)

PEC/PNEC = 0.663 µg/L/40.2 μg/L = 0.016, i.e. PEC/PNEC ≤ 0.1, which justifies the phrase: Use of furosemide has been considered to result in insignificant environmental risk.


Degradation

No degradation data is available, hence justifying the degradation phrase:
"The potential for persistence of furosemid cannot be excluded, due to lack of data".


Bioaccumulation

Partitioning coefficient

Log Kow = 2.03 at neutral pH (experimentally derived, method unknown)
(Ref VI)


Justification of chosen bioaccumulation phrase:

Since log Kow < 4 at pH 7, furosemide has low potential for bioaccumulation.


Excretion (metabolism)

The metabolism of furosemide occurs mainly in the kidneys and the liver, to a smaller extent. The kidneys are responsible for about 85 % of total furosemide total clearance, where about 40 % involves biotransformation. Two major metabolites of furosemide are furosemide glucuronide, which is pharmacologically active, and saluamine (CSA) or 4-chloro-5-sulfamoylanthranilic acid.


The kidneys are responsible for 85 % of total furosemide total clearance, where about 43 % of the drug undergoes renal excretion. Significantly more furosemide is excreted in urine following the I.V. injection than after the tablet or oral solution. Approximately 50 % of the furosemide load is excreted unchanged in urine, and the rest is metabolized into glucuronide in the kidney.
(Ref VII)


References

  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. https://echa.europa.eu/guidance-documents/guidance-on-information-requirements-and-chemical-safety-assessment

  2. Aventis, 2002a, Study report: Furosemide - Growth Inhibition Test with freshwater algae

  3. Aventis, 2002b, Study report: Furosemide – 48 h acute toxicity study in Daphnia magna

  4. Sanofi, Internal Report: Furosemide: Influence to Daphnia magna in a Semi-Static Reproduction Test. Report # 117661221.2017

  5. Hoechst, 1980, Study report: Furosemide – acute toxicity to Leuciscus idus f. melatonus

  6. Source: DrugBank, Human Metabolome Database (HMDB). Sangster J; LOGKOW Databank. Sangster Res. Lab., Montreal Quebec, Canada (1994).

  7. DrugBank - Furosemide, retrieved from Drug Bank 2021-06-04; find here.